Cameron B. Haas, Ph.D., M.P.H.

Rare Cancers Possibly Caused by Viruses

Data from the HIV/AIDS and Transplant Cancer Match Studies reveal higher incidence rates for immunocompromised populations.

Dr. Haas joined the Infections and Immunoepidemiology Branch (IIB) as a postdoctoral fellow in 2021. He earned his Ph.D. and M.P.H. in epidemiology from the University of Washington, Seattle. As a cancer prevention predoctoral trainee, he conducted research in disparities of colorectal cancer screening in a large integrated healthcare system, meta-analyses of surveillance modalities for second breast cancers, and qualitative work on cascade genetic testing. His dissertation work leveraged population-based samples with genetic data to understand predisposing factors related to breast cancer. He received the 2023 NCI Director's Innovation Career Development Award. 

Under the mentorship of Meredith Shiels, Ph.D., M.H.S., senior investigator, IIB, Dr. Haas is working to describe the burden of cancer among people with HIV in the HIV/AIDS Cancer Match Study. In 2022, he was awarded the Intramural AIDS Research Fellowship to describe trends and risk of anal precancer in men and women with and without HIV in the United States. He was awarded the Director’s Career Development Award to describe health-related quality of life among sexual and gender minority adults.